Pervasis Therapeutics explores endothelial cell-based approach to cancer

Wednesday 19 January 2011

Pervasis Therapeutics Inc of Cambridge Massachusetts has announced plans to pursue an endothelial cell-based therapy to target and regulate cell stroma in order to prevent solid tumour growth and metastasis.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States